Resource Center
Explore Resource Types
Focused Solutions
![biologics](https://resources.revvity.com/images/biologics_512x288.jpg)
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
![cell-and-gene-therapy-344x194.jpg](https://resources.revvity.com/images/cell-and-gene-therapy-344x194.jpg)
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
![disease-research_512x288.jpg](https://resources.revvity.com/images/disease-research_512x288.jpg)
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
![Drug Development](https://resources.revvity.com/images/drug-development-thumbnail-512x288.jpg)
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
![functionalgenomic-screeninig512x288](https://resources.revvity.com/images/functionalgenomic-screeninig512x288.jpg)
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
![Integrated Lab Automation](https://resources.revvity.com/images/integrated-lab-automation-thumbnail-512x288.jpg)
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
![physiological-models](https://resources.revvity.com/images/physiological-models_%20512x288.jpg)
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
![Precision Medicine_512x288.jpg](https://resources.revvity.com/images/Precision%20Medicine_512x288.jpg)
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
![drug discovery](https://resources.revvity.com/images/drug-discovery-512x288.jpg)
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
![Design Element](/themes/custom/lsdx_theme/images/background/focused-solutions-end-design.png)
![Design Element](/themes/custom/lsdx_theme/images/background/focused-solutions-end-design-mobile.png)
All Resources
Filters
301 - 312 of 975 Results
![Infographic Icon](/sites/default/files/2024-06/icon-infographic-18.png)
Protein recycling, TPD, and neurodegenerative disease
Targeted protein degradation (TPD) via the proteasomal and lysosomal pathways is
![Application Note Icon](/sites/default/files/2024-06/icon-application-note-18.png)
Optimizing ternary complex assays with AlphaLISA Toolbox reagents for targeted protein degradation…
In this application note, discover how easily Revvity AlphaLISA toolbox reagents
![Guide Icon](/sites/default/files/2024-06/icon-guide-18.png)
Overview guide: know all about radioactivity analysis in drinking water as per regulatory guidelines
This guide book helps researchers working on water anaylsis to develop methods
![Whitepaper Icon](/sites/default/files/2024-06/icon-white-paper-18.png)
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi
![Whitepaper Icon](/sites/default/files/2024-06/icon-white-paper-18.png)
Deconstructing and leveraging 3D structures of RNAs for novel therapeutics
A research team has engineered degradation-resistant mRNAs which could hold
![Case Study Icon](/sites/default/files/2024-06/icon-case-study-18.png)
High-content analysis of drug-induced oligodendrocyte differentiation promoting remyelination in…
Case study describing High-Content Analysis of Drug-Induced Oligodendrocyte
![Publication Icon](/sites/default/files/2024-06/icon-publication-review-18.png)
Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into
![Brochure Icon](/sites/default/files/2024-06/icon-brochure-18.png)
OM50 Ultrasonic Homogenizer and Accessories Brochure
OM50 Ultrasonic Homogenizer and Accessories Brochure
![Brochure Icon](/sites/default/files/2024-06/icon-brochure-18.png)
OM500 Ultrasonic Homogenizer and Accessories Brochure
OM500 Ultrasonic Homogenizer and Accessories Brochure
![Brochure Icon](/sites/default/files/2024-06/icon-brochure-18.png)
OM100 Ultrasonic Homogenizer and Accessories Brochure
OM100 Ultrasonic Homogenizer and Accessories Brochure
![Flyer Icon](/sites/default/files/2024-06/icon-flyer-18.png)
Simply & reduce the cost of hybridization-based target capture with universal blockers
This flyer describes the benefits of the NEXTFLEX® Universal Blockers
![resource-center-page-end-card-bg-illuminator.png](https://resources.revvity.com/images/resource-center-page-end-card-bg-illuminator.png?format=webp&)
![resource-center-page-end-card-bg-illuminator-mobile.png](https://resources.revvity.com/images/resource-center-page-end-card-bg-illuminator-mobile.png?format=webp&)
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.